Esomeprazole Magnesium Patent Expiration

Esomeprazole Magnesium was first introduced by Astrazeneca Pharmaceuticals Lp in its drug Nexium on Feb 20, 2001. Other drugs containing Esomeprazole Magnesium are Esomeprazole Magnesium, Nexium 24Hr. 33 different companies have introduced drugs containing Esomeprazole Magnesium.


Esomeprazole Magnesium Patents

Given below is the list of patents protecting Esomeprazole Magnesium, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Esomeprazole Magnesium US10076494 Stable orally disintegrating pharmaceutical compositions Dec 08, 2036 Dexcel
Esomeprazole Magnesium US10835488 Stable orally disintegrating pharmaceutical compositions Dec 08, 2036 Dexcel
Nexium US6428810

(Pediatric)

Pharmaceutical formulation comprising omeprazole May 03, 2020

(Expired)

Astrazeneca
Nexium 24hr US6428810

(Pediatric)

Pharmaceutical formulation comprising omeprazole May 03, 2020

(Expired)

Astrazeneca Lp
Nexium US6428810 Pharmaceutical formulation comprising omeprazole Nov 03, 2019

(Expired)

Astrazeneca
Nexium 24hr US6428810 Pharmaceutical formulation comprising omeprazole Nov 03, 2019

(Expired)

Astrazeneca Lp
Nexium US6147103

(Pediatric)

Omeprazole process and compositions thereof Apr 09, 2019

(Expired)

Astrazeneca
Nexium US6166213

(Pediatric)

Omeprazole process and compositions thereof Apr 09, 2019

(Expired)

Astrazeneca
Nexium US6191148

(Pediatric)

Omerazole process and compositions thereof Apr 09, 2019

(Expired)

Astrazeneca
Nexium US6369085

(Pediatric)

Form of S-omeprazole Nov 25, 2018

(Expired)

Astrazeneca
Nexium US7411070

(Pediatric)

Form of S-omeprazole Nov 25, 2018

(Expired)

Astrazeneca
Nexium US8466175

(Pediatric)

Form of S-omeprazole Nov 25, 2018

(Expired)

Astrazeneca
Nexium 24hr US6369085

(Pediatric)

Form of S-omeprazole Nov 25, 2018

(Expired)

Astrazeneca Lp
Nexium 24hr US7411070

(Pediatric)

Form of S-omeprazole Nov 25, 2018

(Expired)

Astrazeneca Lp
Nexium 24hr US7411070

(Pediatric)

Form of S-omeprazole Nov 18, 2018

(Expired)

Astrazeneca Lp
Nexium US6147103 Omeprazole process and compositions thereof Oct 09, 2018

(Expired)

Astrazeneca
Nexium US6166213 Omeprazole process and compositions thereof Oct 09, 2018

(Expired)

Astrazeneca
Nexium US6191148 Omerazole process and compositions thereof Oct 09, 2018

(Expired)

Astrazeneca
Nexium US6369085 Form of S-omeprazole May 25, 2018

(Expired)

Astrazeneca
Nexium US7411070 Form of S-omeprazole May 25, 2018

(Expired)

Astrazeneca
Nexium US8466175 Form of S-omeprazole May 25, 2018

(Expired)

Astrazeneca
Nexium 24hr US6369085 Form of S-omeprazole May 25, 2018

(Expired)

Astrazeneca Lp
Nexium 24hr US7411070 Form of S-omeprazole May 25, 2018

(Expired)

Astrazeneca Lp
Nexium 24hr US7411070 Form of S-omeprazole May 18, 2018

(Expired)

Astrazeneca Lp
Nexium US5900424

(Pediatric)

Omeprazole magnesium salt form Nov 04, 2016

(Expired)

Astrazeneca
Nexium 24hr US5900424

(Pediatric)

Omeprazole magnesium salt form Nov 04, 2016

(Expired)

Astrazeneca Lp
Nexium US5900424 Omeprazole magnesium salt form May 04, 2016

(Expired)

Astrazeneca
Nexium 24hr US5900424 Omeprazole magnesium salt form May 04, 2016

(Expired)

Astrazeneca Lp
Nexium US5714504

(Pediatric)

Compositions Aug 03, 2015

(Expired)

Astrazeneca
Nexium 24hr US5714504

(Pediatric)

Compositions Aug 03, 2015

(Expired)

Astrazeneca Lp
Nexium US5690960

(Pediatric)

Pharmaceutical formulation of omeprazole May 25, 2015

(Expired)

Astrazeneca
Nexium 24hr US5690960

(Pediatric)

Pharmaceutical formulation of omeprazole May 25, 2015

(Expired)

Astrazeneca Lp
Nexium US5714504 Compositions Feb 03, 2015

(Expired)

Astrazeneca
Nexium 24hr US5714504 Compositions Feb 03, 2015

(Expired)

Astrazeneca Lp
Nexium US5877192

(Pediatric)

Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole Nov 27, 2014

(Expired)

Astrazeneca
Nexium US6875872

(Pediatric)

Compounds Nov 27, 2014

(Expired)

Astrazeneca
Nexium 24hr US5877192

(Pediatric)

Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole Nov 27, 2014

(Expired)

Astrazeneca Lp
Nexium 24hr US6875872

(Pediatric)

Compounds Nov 27, 2014

(Expired)

Astrazeneca Lp
Nexium US5690960 Pharmaceutical formulation of omeprazole Nov 25, 2014

(Expired)

Astrazeneca
Nexium 24hr US5690960 Pharmaceutical formulation of omeprazole Nov 25, 2014

(Expired)

Astrazeneca Lp
Nexium US5877192 Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole May 27, 2014

(Expired)

Astrazeneca
Nexium US6875872 Compounds May 27, 2014

(Expired)

Astrazeneca
Nexium 24hr US5877192 Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole May 27, 2014

(Expired)

Astrazeneca Lp
Nexium 24hr US6875872 Compounds May 27, 2014

(Expired)

Astrazeneca Lp



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Esomeprazole Magnesium's patents.

Given below is the list recent legal activities going on the following patents of Esomeprazole Magnesium.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 09 May, 2024 US10835488
Payment of Maintenance Fee, 4th Year, Large Entity 14 Feb, 2022 US10076494
Recordation of Patent Grant Mailed 17 Nov, 2020 US10835488
Patent Issue Date Used in PTA Calculation 17 Nov, 2020 US10835488
Email Notification 29 Oct, 2020 US10835488
Issue Notification Mailed 28 Oct, 2020 US10835488
Email Notification 13 Oct, 2020 US10835488
Mailing Corrected Notice of Allowability 13 Oct, 2020 US10835488
Dispatch to FDC 10 Oct, 2020 US10835488
Corrected Notice of Allowability 07 Oct, 2020 US10835488


Esomeprazole Magnesium's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Esomeprazole Magnesium Generic API Manufacturers

Several generic applications have been filed for Esomeprazole Magnesium. The first generic version for Esomeprazole Magnesium was by Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa and was approved on Jan 26, 2015. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on Oct 23, 2024.

Given below is the list of companies who have filed for Esomeprazole Magnesium generic, along with the locations of their manufacturing plants worldwide.


1. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE

capsule, delayed rel pellets Prescription ORAL AB Oct 20, 2017
EQ 20MG BASE

capsule, delayed rel pellets Prescription ORAL AB Oct 20, 2017





2. AMNEAL PHARMS NY

Amneal Pharmaceuticals Of Ny Llc has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Amneal Pharms Ny.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE

capsule, delayed rel pellets Discontinued ORAL N/A Apr 10, 2019
EQ 20MG BASE

capsule, delayed release Over the counter ORAL N/A Jun 5, 2019





3. ANDA REPOSITORY

Anda Repository Llc has filed for 1 generic for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Anda Repository.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

capsule, delayed release Over the counter ORAL N/A Mar 15, 2023





4. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 1 generic for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

capsule, delayed release Over the counter ORAL N/A Oct 16, 2017


Manufacturing Plant Locations
New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country City Firm Name
India
Polepally, Mahaboob Nagar Aurobindo Pharma Limited
Bachupally Aurobindo Pharma Limited
Medchal Aurobindo Pharma Ltd
Sangareddy Aurobindo Pharma Limited
United States
East Windsor Aurobindo Pharma USA Inc





5. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

tablet, delayed release Over the counter ORAL N/A Jul 12, 2023
EQ 40MG BASE

capsule, delayed rel pellets Prescription ORAL AB Apr 21, 2016


Manufacturing Plant Locations
New

Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd





6. CIPLA

Cipla Ltd has filed for 3 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Cipla.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE/PACKET

for suspension, delayed release Prescription ORAL AB Mar 23, 2020
EQ 10MG BASE/PACKET

for suspension, delayed release Prescription ORAL AB Mar 23, 2020
EQ 40MG BASE/PACKET

for suspension, delayed release Prescription ORAL AB Mar 23, 2020


Manufacturing Plant Locations
New

Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.

Country City Firm Name
India
Bangalore Cipla Ltd.
Vasco Da Gama Cipla Limited
Kurkumbh Village, Dist. Pune Cipla, Ltd.
Pithampur, District Dhar Cipla Limited
Bengaluru Cipla Limited
Raigad Cipla Limited
Mumbai Cipla Limited





7. CISEN

Cisen Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Cisen.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE

capsule, delayed rel pellets Prescription ORAL AB Sep 22, 2020
EQ 20MG BASE

capsule, delayed rel pellets Prescription ORAL AB Sep 22, 2020





8. CSPC OUYI

Cspc Ouyi Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Cspc Ouyi.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

capsule, delayed rel pellets Prescription ORAL AB Oct 2, 2020
EQ 40MG BASE

capsule, delayed rel pellets Prescription ORAL AB Oct 2, 2020


Manufacturing Plant Locations
New

Cspc Ouyi's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Cspc Ouyi as present at those locations.

Country City Firm Name
China
Shijiazhuang CSPC Ouyi Pharmaceutical Co., Ltd.





9. DR REDDYS

Dr Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

capsule, delayed release Over the counter ORAL N/A Apr 30, 2024
EQ 40MG BASE

capsule, delayed rel pellets Prescription ORAL AB Sep 25, 2015





10. ETHYPHARM

Ethypharm Sa has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Ethypharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

capsule, delayed rel pellets Prescription ORAL AB Mar 31, 2021
EQ 40MG BASE

capsule, delayed rel pellets Prescription ORAL AB Mar 31, 2021


Manufacturing Plant Locations
New

Ethypharm's manufacturing plants are situated in 2 countries - France, United States. Given below are the details of these plant locations as well as the firm names of Ethypharm as present at those locations.

Country City Firm Name
France
Le Grand Quevilly CEDEX Ethypharm
Chateauneuf En Thymerais Ethypharm
United States
Philadelphia Ethypharm Usa Corp





11. GLENMARK SPECLT

Glenmark Specialty Sa has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Glenmark Speclt.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE

capsule, delayed rel pellets Discontinued ORAL N/A May 10, 2019
EQ 20MG BASE

capsule, delayed release Over the counter ORAL N/A Jun 11, 2024





12. GRANULES

Granules India Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Granules.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

capsule, delayed rel pellets Prescription ORAL AB Oct 18, 2023
EQ 40MG BASE

capsule, delayed rel pellets Prescription ORAL AB Oct 18, 2023


Manufacturing Plant Locations
New

Granules's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Granules as present at those locations.

Country City Firm Name
United States
Manassas Granules Consumer Health Inc.
Chantilly Granules Pharmaceuticals Inc.
India
Sangareddy District Granules India Limited
Visakhapatnam Granules India Limited
Secunderabad Granules India Limited
Parawada Mandal Granules India Limited
Medchal-Malkhajgiri District Granules India Limited





13. GRAVITI PHARMS

Graviti Pharmaceuticals Private Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Graviti Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE

capsule, delayed rel pellets Prescription ORAL AB Mar 19, 2021
EQ 20MG BASE

capsule, delayed release Over the counter ORAL N/A Jun 24, 2022





14. GUANGZHOU NOVAKEN

Guangzhou Novaken Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Guangzhou Novaken.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

capsule, delayed rel pellets Prescription ORAL AB Nov 18, 2020
EQ 40MG BASE

capsule, delayed rel pellets Prescription ORAL AB Nov 18, 2020





15. HEC PHARM

Hec Pharm Usa Inc has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Hec Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE

capsule, delayed rel pellets Discontinued ORAL N/A May 18, 2018
EQ 20MG BASE

capsule, delayed rel pellets Discontinued ORAL N/A May 18, 2018


Manufacturing Plant Locations
New

Hec Pharm's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Hec Pharm as present at those locations.

Country City Firm Name
China
Yidu HEC Pharm Co., Ltd.





16. HETERO LABS LTD III

Hetero Labs Ltd Unit Iii has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

capsule, delayed rel pellets Prescription ORAL AB Jun 2, 2020
EQ 40MG BASE

capsule, delayed rel pellets Prescription ORAL AB Jun 2, 2020





17. INDCHEMIE HEALTH

Indchemie Health Specialties Pvt Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Indchemie Health.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE

capsule, delayed rel pellets Prescription ORAL AB Feb 26, 2021
EQ 20MG BASE

capsule, delayed rel pellets Prescription ORAL AB Feb 26, 2021





18. IVAX SUB TEVA PHARMS

Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Ivax Sub Teva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

capsule, delayed rel pellets Prescription ORAL AB Jan 26, 2015
EQ 40MG BASE

capsule, delayed rel pellets Prescription ORAL AB Jan 26, 2015





19. LANNETT CO INC

Lannett Co Inc has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

capsule, delayed rel pellets Prescription ORAL AB Sep 1, 2017
EQ 40MG BASE

capsule, delayed rel pellets Prescription ORAL AB Sep 1, 2017





20. MACLEODS PHARMS LTD

Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

capsule, delayed rel pellets Prescription ORAL AB Oct 23, 2024
EQ 40MG BASE

capsule, delayed rel pellets Prescription ORAL AB Oct 23, 2024





21. MARKSANS PHARMA

Marksans Pharma Ltd has filed for 1 generic for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Marksans Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

capsule, delayed release Over the counter ORAL N/A Sep 29, 2023


Manufacturing Plant Locations
New

Marksans Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Marksans Pharma as present at those locations.

Country City Firm Name
United States
Commack Marksans Pharmaceuticals Ltd
India
Verna Marksans Pharma Limited





22. MYLAN

Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

tablet, delayed release Over the counter ORAL N/A Jun 25, 2020
EQ 40MG BASE

capsule, delayed rel pellets Prescription ORAL AB Aug 3, 2015


Manufacturing Plant Locations
New

Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.

Country City Firm Name
United States
Santa Barbara Mylandon LLC dba Debbie s Delights Santa Barbara Baking Co.
San Carlos Mylan Pharmaceuticals Inc.
Saint Albans Mylan Technologies, Inc.
Morgantown Mylan Specialty, L.P.
Greensboro Mylan Pharmaceuticals Inc
Morgantown MYLAN CONSUMER HEALTHCARE Inc.
Rockford Mylan Institutional, Inc.
India
Anekal Taluk, Bangalore Mylan Laboratories Limited
Sinnar Mylan Laboratories Limited
Hosur Mylan Laboratories Limited
Hyderabad Mylan Laboratories Limited
Bangalore Mylan Laboratories Limited
Sarigam Mylan Laboratories Limited
Aurangabad Mylan Laboratories Limited (FDF-2)
Pithampur, District Dhar Mylan Laboratories Limited
Canada
Etobicoke Mylan Pharmaceuticals ULC
Ireland
Inverin Mylan Teoranta





23. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 1 generic for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

capsule, delayed release Discontinued ORAL N/A Oct 16, 2019





24. P AND L

P And L Development Llc has filed for 1 generic for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by P And L.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

tablet, delayed release Discontinued ORAL N/A Mar 5, 2019





25. PERRIGO R AND D

Perrigo R And D Co has filed for 1 generic for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Perrigo R And D.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

capsule, delayed release Over the counter ORAL N/A Aug 18, 2017





26. PRINSTON INC

Prinston Pharmaceutical Inc has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Prinston Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

capsule, delayed rel pellets Prescription ORAL AB Mar 28, 2023
EQ 40MG BASE

capsule, delayed rel pellets Prescription ORAL AB Mar 28, 2023





27. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE

capsule, delayed rel pellets Prescription ORAL AB Apr 30, 2018
EQ 20MG BASE

capsule, delayed release Over the counter ORAL N/A May 4, 2020


Manufacturing Plant Locations
New

Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.

Country City Firm Name
United States
Billerica Sun Pharmaceutical Industries, Inc.
Lexington Sun Pharmaceutical Industries Inc
Princeton SUN PHARMACEUTICAL INDUSTRIES INC
India
New Delhi Sun Pharmaceutical Industries Limited
Punjab Sun Pharmaceutical Industries, Inc.
Ahmednagar Sun Pharmaceutical Industries Limited
Dadra Sun Pharmaceutical Industries Limited
Vadodara Sun Pharmaceutical Industries Limited - Karkhadi
Vadodara Sun Pharmaceutical Industries Ltd.
Malanpur, Bhind (District) Sun Pharmaceutical Industries Limited
Kanchipuram Sun Pharmaceutical Industries Limited- Madhuranthagam
Vadodara Sun Pharmaceutical Industries Ltd
Bharuch Sun Pharmaceutical Industries Ltd
Baruch Sun Pharmaceutical Industries Ltd.
Halol Sun Pharmaceutical Industries Ltd.
Mohali Sun Pharmaceutical Industries Limited
Gurugram Sun Pharmaceutical Industries Limited (prev. Ranbaxy)





28. TORRENT

Torrent Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Torrent.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

capsule, delayed rel pellets Discontinued ORAL N/A Oct 19, 2015
EQ 40MG BASE

capsule, delayed rel pellets Discontinued ORAL N/A Oct 19, 2015


Manufacturing Plant Locations
New

Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.

Country City Firm Name
India
Bharuch Torrent Pharmaceuticals Limited
Pithampur Torrent Pharmaceuticals Limited
Thanam Torrent Pharmaceuticals Limited
Gandhi Nagar Torrent Pharmaceuticals Limited
Indrad Torrent Pharmaceuticals Limited
United States
Basking Ridge Torrent Pharma Inc.
Kalamazoo Torrent Pharma Inc.





29. ZHEJIANG YONGTAI

Zhejiang Yongtai Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Zhejiang Yongtai.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

capsule, delayed rel pellets Prescription ORAL AB Dec 27, 2023
EQ 40MG BASE

capsule, delayed rel pellets Prescription ORAL AB Dec 27, 2023


Manufacturing Plant Locations
New

Zhejiang Yongtai's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Zhejiang Yongtai as present at those locations.

Country City Firm Name
China
Linhai Zhejiang Yongtai Pharmaceutical Co. Ltd





30. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Esomeprazole Magnesium. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

capsule, delayed rel pellets Prescription ORAL AB May 22, 2019
EQ 40MG BASE

capsule, delayed rel pellets Prescription ORAL AB May 22, 2019
EQ 20MG BASE/PACKET

for suspension, delayed release Prescription ORAL AB Jun 7, 2023
EQ 40MG BASE/PACKET

for suspension, delayed release Prescription ORAL AB Jun 7, 2023